Sharpening a Double-Edged Sword: Bispecific CAR-T Cancer Therapies

Back to Webinars

Featured Speakers: David Miklos, MD, PhD, Chief Clinical Director, Blood and Marrow Transplantation and Cellular Therapy, Cancer Cell Therapy Stanford University

What's Inside

In this Webinar we discuss:

CAR-T benefits are T cell dependent

Treatment schema for CAR-T cell therapy

Explore several case studies

Watch the Webinar

Back to the Top